Martingale Asset Management L P Blueprint Medicines Corp Transaction History

Martingale Asset Management L P

$4.27 Billion
Q3 2024

A detailed history of Martingale Asset Management L P transactions in Blueprint Medicines Corp stock. As of the latest transaction made, Martingale Asset Management L P holds 15,603 shares of BPMC stock, worth $1.41 Million. This represents 0.03% of its overall portfolio holdings.

Number of Shares

15,603

Previous 14,505 7.57%

Holding current value

$1.41 Million

Previous $1.56 Million 7.74%

% of portfolio

0.03%

Previous 0.03%

15 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 14, 2024	BUY	$84.1 - $120.5 $92,341 - $132,309	1,098 Added 7.57%	15,603 $1.44 Million
Q2 2024 Aug 12, 2024	BUY	$85.18 - $108.78 $41,738 - $53,302	490 Added 3.5%	14,505 $1.56 Million
Q1 2024 May 14, 2024	SELL	$73.17 - $99.79 $21,951 - $29,937	-300 Reduced 2.1%	14,015 $1.33 Million
Q4 2023 Feb 12, 2024	SELL	$43.96 - $92.84 $79,040 - $166,926	-1,798 Reduced 11.16%	14,315 $1.32 Million
Q3 2023 Nov 14, 2023	SELL	$46.9 - $66.0 $5,018 - $7,062	-107 Reduced 0.66%	16,113 $809,000
Q2 2023 Aug 11, 2023	SELL	$42.2 - $66.37 $16,964 - $26,680	-402 Reduced 2.42%	16,220 $1.03 Million
Q1 2023 May 12, 2023	BUY	$37.97 - $50.0 $631,137 - $831,100	16,622 New	16,622 $747,000
Q1 2022 May 12, 2022	SELL	$54.1 - $110.08 $877,772 - $1.79 Million	-16,225 Closed	0 $0
Q4 2021 Feb 11, 2022	SELL	$94.25 - $115.99 $1.04 Million - $1.28 Million	-11,053 Reduced 40.52%	16,225 $1.74 Million
Q3 2021 Nov 12, 2021	BUY	$80.98 - $109.47 $1.04 Million - $1.41 Million	12,860 Added 89.19%	27,278 $2.8 Million
Q2 2021 Aug 13, 2021	BUY	$82.78 - $101.0 $811,823 - $990,507	9,807 Added 212.69%	14,418 $1.27 Million
Q1 2021 May 13, 2021	BUY	$90.71 - $108.28 $100,143 - $119,541	1,104 Added 31.48%	4,611 $448,000
Q4 2020 Feb 10, 2021	SELL	$92.08 - $124.48 $515,279 - $696,590	-5,596 Reduced 61.47%	3,507 $393,000
Q3 2020 Nov 12, 2020	SELL	$66.45 - $92.7 $93,030 - $129,780	-1,400 Reduced 13.33%	9,103 $843,000
Q2 2020 Aug 10, 2020	BUY	$57.09 - $79.27 $599,616 - $832,572	10,503 New	10,503 $819,000

Others Institutions Holding BPMC

# of Institutions

351

Shares Held

60.3M

Call Options Held

2.25M

Put Options Held

1.18M

View Full List

About Blueprint Medicines Corp

Ticker BPMC
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 59,719,600
Market Cap $5.4B
Description
Blueprint Medicines Corporation, a precision therapy company, develops medicines for genomically defined cancers and blood disorders in the United States and internationally. The company is developing AYVAKIT for the treatment of systemic mastocytosis (SM) and gastrointestinal stromal tumors; BLU-263, an orally available, potent, and KIT inhibit...

More about BPMC

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Martingale Asset Management L P, based on Form 13F filings with the SEC.

News

Stay updated on Martingale Asset Management L P with notifications on news.

Account

Martingale Asset Management L P Blueprint Medicines Corp Transaction History